Please Wait...

Classic Blog

New Apps Emerge for RBM!

  • 0
  • 09 May

App xChange adds Virtual Onsite Monitoring (VOS)

In advising and providing consulting to many different companies in recent years making a switch to risk-based monitoring (RBM) it's become apparent to me that the opportunity to improve patient safety and enhance data quality is the top reason for adoption.  Later this year when the revised ICH E6 (R2) guidance goes into effect we will have even more incentive to adopt RBM!

Read More
Bioclinica on Worldwide Business with Kathy Ireland

Worldwide Business with Kathy Ireland features Bioclinica!

  • 0
  • 06 May

Catch a candid discussion with Bioclinica experts as they discuss clinical trials and ways to simplify the clinical development process in a recent episode of Worldwide Business with Kathy Ireland®!

Each week the Fox Business Network sponsored program explores the real-world insights of corporate executives from around the globe.

Read More

Seamless integration: Getting more from financial management technology

  • 0
  • 26 Apr

Sitting in the CFO seat for several years opened my eyes to the significant role spreadsheets have played in financial management in industries such as clinical trials – and their many shortcomings in managing finances. Once the go-to method, spreadsheets are rapidly falling by the wayside as organizations recognize that automated solutions are not time-consuming, cumbersome and error-prone like spreadsheets are.

Read More

Seeking Clarity in the Audit Approach

  • 0
  • 18 Apr

Many questions still remain several years after the July 2012 ODAC (Oncologic Drug Advisory Committee) Meeting on the "Evaluation of Radiologic Review of Progression-free Survival in Non-Hematologic Malignancies." Further investigation was recommended into the utility of taking an audit approach (central reads of a test sample) to identify potential bias in the local evaluation (LE) of patient data.

Read More

Pharmacovigilance in the EU: Master the requirements before marketing medicines

  • 0
  • 05 Apr

Planning to market medicines in the EU?

If you are, having a firm grasp of Good Pharmacovigilance Practices (GVP) requirements within the EU legislation is important. A knowledge gap in any area of the 16 GVP modules can surface as a compliance problem during an audit or inspection, carrying a hefty penalty and delaying regulatory approval. In extreme cases, a regulatory misstep or oversight can lead to forced withdrawal of a product from market.

Read More

RBM is Advancing: 3 Keys in Planning

  • 0
  • 09 Mar

While Miami warmth and sunshine in February was undoubtedly a main draw for some SCOPE Summit attendees, for the risk-based monitoring set it was something more. It was about the opportunity for our diverse group of stakeholders to come together and give feedback in an area increasingly growing in importance - quality and risk management.

Read More

Governance and Collaboration: CTMS Checklist

  • 0
  • 02 Mar

A recent market research report forecasts that the eClinical solutions market will be worth 5.98 billion (USD) by 2020. With sponsors and CROs adopting new eClinical software, or replacing legacy systems, such as clinical trial management systems (CTMS), vendors are emerging with new software to stake a claim in this growing market.

Read More

The Scoop from SCOPE Summit 2016

  • 0
  • 25 Feb

SCOPE Summit 2016 was a busy and exciting event for the Bioclinica team! In addition to the great discussions at the Bioclinica booth, Ron Burns, VP, Product Management, Bioclinica eHealth Solutions, held a session entitled, "Integrating Mobile Application Generated Patient Data into Your Risk-Based Monitoring Strategy." This session included Bioclinica eHealth App xChange Partner, AiCure.

Read More

Get a First-Hand Glimpse into the Power of Mobile Application Generated Patient Data at SCOPE Summit 2016

  • 0
  • 18 Feb

The rapid growth of technology is revolutionizing the way clinical trials are conducted. Increasing adoption of smartphone use -- forecasted to reach over 6 billion by 2021 – combined with the growing biosensors market opens up new possibilities for a variety of healthcare-related uses. Innovative patient-centered mobile applications and biosensors now connect patients with physicians and other healthcare providers.

Read More

Prompt Site Payments Key to Site Engagement

  • 0
  • 05 Feb

When it comes to achieving success in clinical trials, it truly takes a team. Sponsors, investigative sites and patients must work in partnership to complete this important work. However, with weighty matters in the clinical development process - shrinking pipelines, shortened patent life, patient population considerations, global safety standards, and the list goes on - the needs of investigative sites can be overshadowed.

Read More
CDISC

CDISC Public Courses in Audubon, March 2-12: Register with CDISC today!

  • 0
  • 04 Feb

Here's a great opportunity to learn CDISC from CDISC at Public Courses being held in Audubon, Pennsylvania at Bioclinica's eHealth Headquarters on March 2-12. (Other dates and locations are available).

Why take CDISC Training?

Read More

Necessity and Associated Benefits of Having Post-Approval Specific Technology

  • 0
  • 26 Jan

Over the last decade, across the globe, the regulatory landscape has changed considerably, with greater focus and awareness on pharmaceutical products post-approval. Legislation, coupled with public concerns about the safety of marketed drugs and the need to evaluate safety and effectiveness of the marketed products in a real-world setting is forcing many companies to embark on post-approval research.

Read More

Pages

ROI Initiative: A Technology Solution for Investigator Payments

  • 0
  • 12 Jan

Managing investigator payments faces specific, well-known challenges. Current systems are fragmented and manual, and in most cases are not transactional or financial-based.

The result of continuing with current processes is the inability to manage the complexity of the contract and budget terms that are negotiated and paid throughout the course of a clinical trial. Current document management systems (e.g., CTMS and other homegrown systems) are based on non-financial system information that doesn’t manage or account for the accuracy of payments made.

Read More

Is It Time to Embed Supply Chain Forecasting in Interactive Response Technology?

  • 0
  • 04 Jan

Some of my Bioclinica colleagues and I recently attended CBI's IRT 2016 conference in Philadelphia. While there were plenty of interesting topics discussed at the conference, one presentation particularly stuck out to me: the benefits of connecting supply chain forecasting for clinical trials more closely with interactive response technology (IRT) software. The reliance of effective clinical trial forecasting on IRT data is well understood within the clinical trial world, and was a big talking point at the conference.

Read More

Meet the Bioclinica eClinical Team: Kristin Mauri, Global Head of Risk-Based Monitoring

  • 0
  • 18 Nov

Bioclinica's suite of eClinical solutions is designed to make your next clinical trial easier for you, your investigators and even your subjects. Our flexible and innovative eClinical solutions are supported by a team of people who have experience in all facets of clinical trials and help our clients seamlessly adopt new technologies and processes to improve their trials. Our team members are invaluable to our success, so we wanted to highlight a few of them in a "Meet the Team" blog series.

Read More

Meet the Bioclinica Safety and Regulatory Team: Sukrit Singh, Engagement Manager

  • 0
  • 07 Nov

Bioclinica's Safety and Regulatory Solutions division provides optimal drug safety, regulatory affairs and clinical services to CROs and sponsors. Our services are supported by our knowledgeable team members, who have experience in a wide variety of roles within the safety and regulatory sphere of clinical trials.

Read More

Pages

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

@ArenaIntPharma pls contact our events coordinator via traditional channels
bioclinica (30 minutes ago)
eHealth Solutions president Mukhtar Ahmed speaking at #phorum17 Apr. 27 https://t.co/OaBPodxZBF https://t.co/QjHQR1LbU1
bioclinica (54 minutes ago)
Join @Bioclinica April 28 at NJ Statewide Career & Internship Fair, Rutgers Univ. https://t.co/NH3wsToDTh
bioclinica (1 hour ago)
RT @MySCRS: 96.7% of patients want to know results of #ClinicalTrials yet only 9% are able to find them after study ends. https://t.co/SxtG…
bioclinica (1 hour ago)
RT @SCDM_DataDriven: SCDM is looking for volunteers to revise the Certification Exam! Are you interested? Learn more https://t.co/X7ZYvur2fm
bioclinica (1 hour ago)
RT @ACROhealth: Follow #CTAW2017 next week to learn how more #clinicaltrial participation could help us discover better treatments. https:/…
bioclinica (1 hour ago)

Latest Blogs: